blog

So much of the focus of clinical trial participation is on the patient and reducing site staff burden. But sometimes we forget about the role of the caregiver. After all, it is usually the caregiver driving the patient to their appointments, managing medication schedules, taking notes at doctor’s appointments, and much more. It makes you wonder: who is the caregiver’s caregiver? Enter Zaggo, a non-profit organization that provides the tools caregivers need to take care of their loved one as effectively and efficiently as possible.

Zaggo was born out of the experience of its founder and president, Roberta Carson, after she was thrust into the role of caregiver for her son Zachary during his 27-month battle with pediatric brain cancer.

Topics: Pharma15, Patient Experience, Most Viewed

Georgia Mitsi spoke with BBK Worldwide’s Aaron Fleishman about her company’s newest app E.V.A — an engagement platform for patients who suffer from chronic neurological conditions. Says Mitsi: “It’s about evaluate, validate and act.”

Topics: Pharma15, clinical research, clinical trials, Disruptive Innovation, digital, devices, BYOD, provisional device, Most Viewed

What does patient data ownership actually mean? According to Craig Lipset, head of clinical innovation at Pfizer and DPharm 2018 co-chair, that is still an open question. Pharma15 Live! chatted with him about it at the DPharm 2018 conference.

Topics: Pharma15, Patient Experience, clinical research, clinical trials, patient data, Disruptive Innovation, Conferences, Most Viewed

With regard to the adoption and use of digital health solutions in clinical R&D, where are we as an industry? In our latest Pharma15 Live! debate, BBK Worldwide founding principal Bonnie A. Brescia posed this question to the panel of industry experts. Justin Johnson, CEO of Biotaware, answered in no uncertain terms: “[the industry] is five to eight years behind where it should be.” Do you agree?

Topics: Pharma15, Most Viewed

There are probably a good number of us in the clinical research and development industry that are spending a lot of time dotting the i’s and crossing the t’s on their Privacy Policies and otherwise ensuring that everything is ready for the 25^th of May, the day that the EU’s General Data Protection Regulation (GDPR) goes into effect. And, there are probably a good number of us who have had a rather intense schedule over the past few months. But, I bet if you conducted a poll, you’d find that despite all the time-consuming work and activity, those of us concerned with the patient experience are greatly pleased that GDPR is finally here.

Topics: Most Viewed

For our latest eBook 21st Century Research Champions, we reached out to physicians to gain a deeper understanding about their attitudes and actions with regard to clinical research, and explored tested strategies in building relationships with physicians to enhance patient recuritment. As it turns out, physicians were more than happy to provide their insights into the value of referring physician programs and to elaborate on their willingness to contribute to clinical research. We interviwed Dr. Eliott Rosenstein -- a physician with more than 40 years of experience and Director of the Institute for Rheumatic and Autoimmune diseases -- to get his take on our latest eBook and the importance of referring physicians in clinical trial patient recruitment.

Topics: Physician Referrals, clinical research, clinical trials, Most Viewed

Picture this: a clammy Nicolas Cage sits hunched forward in the driver’s seat of a $5m hypercar, gripping the top of the steering wheel and staring at an undefined point just beyond the camera.

His grip on the wheel tightens and he punches the accelerator.

In a cacophony of protesting rubber and tire smoke, he’s Gone in 60 Seconds.

Sound familiar? I’m making a tenuous but spellbinding opening remark to get our blood flowing about advertising. Not just advertising in general but also, more specifically, patient recruitment advertising. 

Topics: clinical research, advertising, Most Viewed